Stay updated on COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Sign up to get notified when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.
Latest website image capture
Clouds background image

Latest updates to the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The study record history now includes a newer submitted version dated 2026-04-21 and associated “more information” and results-related sections, indicating the trial’s core metadata and reporting content were updated. It replaces an earlier revision (v3.5.2) reference with the latest revision (v3.5.3), consistent with an updated ClinicalTrials.gov record version.
    Difference
    0.5%
    Check dated 2026-04-24T05:23:45.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added revision v3.5.2 and deleted revision v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:09:28.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    In the log, Revision: v3.5.0 was added and Revision: v3.4.3 was crossed out.
    Difference
    0.0%
    Check dated 2026-03-19T00:01:33.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added, replacing v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T18:09:05.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added as the latest version in the study's history, replacing the earlier v3.4.1. The notice about government funding and operating status was removed from the page.
    Difference
    0.3%
    Check dated 2026-02-11T09:27:53.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The page shows two minor administrative updates: a site-wide notice regarding government funding and a new revision tag (v3.4.1) that supersedes v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T05:56:02.000Z thumbnail image

Stay in the know with updates to COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Enter your email address, and we'll notify you when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.